Cargando…
Targeting the Expanded TCF4/Fuchs’ Endothelial Corneal Dystrophy CUG Repeat with Morpholino Peptide Conjugates
[Image: see text] Fuchs’ corneal endothelial dystrophy (FECD) is a major cause of vision loss. Corneal transplantation is the only effective curative treatment, but this surgery has limitations. A pharmacological intervention would complement surgery and be beneficial for many patients. FECD is caus...
Autores principales: | Hu, Jiaxin, Shen, Xiulong, Kheirabadi, Mahboubeh, Streeter, Matthew D., Qian, Ziqing, Mootha, V. Vinod, Corey, David R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10652360/ https://www.ncbi.nlm.nih.gov/pubmed/38024683 http://dx.doi.org/10.1021/acsomega.3c05634 |
Ejemplares similares
-
The TCF4 Trinucleotide Repeat Expansion of Fuchs’ Endothelial Corneal Dystrophy: Implications for the Anterior Segment of the Eye
por: Hu, Jiaxin, et al.
Publicado: (2023) -
Quantitative Studies of Muscleblind Proteins and Their Interaction With TCF4 RNA Foci Support Involvement in the Mechanism of Fuchs' Dystrophy
por: Rong, Ziye, et al.
Publicado: (2019) -
Instability of TCF4 Triplet Repeat Expansion With Parent–Child Transmission in Fuchs' Endothelial Corneal Dystrophy
por: Saade, Joanna S., et al.
Publicado: (2018) -
Oligonucleotides targeting TCF4 triplet repeat expansion inhibit RNA foci and mis-splicing in Fuchs’ dystrophy
por: Hu, Jiaxin, et al.
Publicado: (2018) -
Fuchs' Endothelial Corneal Dystrophy and RNA Foci in Patients With Myotonic Dystrophy
por: Mootha, V. Vinod, et al.
Publicado: (2017)